Sexual Dysfunction associated with Second-Generation Antidepressants in Patients with Major Depressive Disorder: Results from a Systematic Review with Network Meta-Analysis

被引：0
|
作者：
Ursula Reichenpfader
Gerald Gartlehner
Laura C. Morgan
Amy Greenblatt
Barbara Nussbaumer
Richard A. Hansen
Megan Van Noord
Linda Lux
Bradley N. Gaynes
机构：
[1] Danube University Krems,Department for Evidence
[2] RTI International,based Medicine and Clinical Epidemiology
[3] Auburn University,Department of Psychiatry
[4] University of North Carolina School of Medicine Chapel Hill,Division of Community Medicine, Department of Medical and Health Sciences
[5] Linköping University,undefined
来源：
Drug Safety | 2014年 / 37卷
关键词：
Major Depressive Disorder; Paroxetine; Sexual Dysfunction; Bupropion; Duloxetine;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：19 / 31
页数：12
相关论文
共 50 条
  • [21] Antidepressants available in Japan for older people with major depressive disorder: A systematic review and meta-analysis
    Kishi, Taro
    Sakuma, Kenji
    Hatano, Masakazu
    Okumura, Takenori
    Kato, Masaki
    Baba, Hajime
    Iwata, Nakao
    NEUROPSYCHOPHARMACOLOGY REPORTS, 2024, 44 (01) : 267 - 271
  • [22] Meta-analysis: Risk of hyperhidrosis with second-generation antidepressants
    Beyer, Chad
    Cappetta, Kiley
    Johnson, Jessica A.
    Bloch, Michael H.
    DEPRESSION AND ANXIETY, 2017, 34 (12) : 1134 - 1146
  • [23] A systematic review and meta-analysis of lithium augmentation of tricyclic and second generation antidepressants in major depression
    Nelson, J. Craig
    Baumann, Pierre
    Delucchi, Kevin
    Joffe, Russell
    Katona, Cornelius
    JOURNAL OF AFFECTIVE DISORDERS, 2014, 168 : 269 - 275
  • [24] Phosphodiesterase type 5 inhibitors for the treatment of sexual dysfunction in males with major depressive disorder: A systematic review and meta-analysis
    Sakuma, Kenji
    Kishi, Taro
    Sanji, Shohei
    Nomura, Ikuo
    Hatano, Masakazu
    Okuya, Makoto
    Iwata, Nakao
    PSYCHIATRY AND CLINICAL NEUROSCIENCES, 2023, 77 (05)
  • [25] Intranasal esketamine for patients with major depressive disorder: A systematic review and meta-analysis
    Oraee, Soroush
    Alinejadfard, Mohammadreza
    Golsorkh, Hossein
    Sadeghian, Majid
    Fanaei, Maryam
    Centis, Rosella
    D'Ambrosio, Lia
    Sotgiu, Giovanni
    Goudarzi, Hossein
    Migliori, Giovanni Battista
    Nasiri, Mohammad Javad
    JOURNAL OF PSYCHIATRIC RESEARCH, 2024, 180 : 371 - 379
  • [26] Functioning in patients with major depressive disorder in remission: A systematic review and meta-analysis
    Schwarz, Rasmus
    Munkholm, Klaus
    Christensen, Mie S.
    Kessing, Lars, V
    Vinberg, Maj
    JOURNAL OF AFFECTIVE DISORDERS, 2024, 363 : 112 - 123
  • [27] Optimally combining transcranial magnetic stimulation with antidepressants in major depressive disorder: A systematic review and Meta-analysis
    Rakesh, Gopalkumar
    Cordero, Patrick
    Khanal, Rebika
    Himelhoch, Seth S.
    Rush, Craig R.
    JOURNAL OF AFFECTIVE DISORDERS, 2024, 358 : 432 - 439
  • [28] The Cognitive Effects of Antidepressants in Major Depressive Disorder: A Systematic Review and Meta-Analysis of Randomized Clinical Trials
    Rosenblat, Joshua D.
    Kakar, Ron
    McIntyre, Roger S.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2016, 19 (02):
  • [29] Discontinuation of antidepressants after remission with antidepressant medication in major depressive disorder: a systematic review and meta-analysis
    Kato, Masaki
    Hori, Hikaru
    Inoue, Takeshi
    Iga, Junichi
    Iwata, Masaaki
    Inagaki, Takahiko
    Shinohara, Kiyomi
    Imai, Hissei
    Murata, Atsunobu
    Mishima, Kazuo
    Tajika, Aran
    MOLECULAR PSYCHIATRY, 2021, 26 (01) : 118 - 133
  • [30] Repetitive transcranial magnetic stimulation combined with antidepressants for major depressive disorder: A meta-analysis and systematic review
    Maneeton, B.
    Maneeton, N.
    Woottiluk, P.
    Oonarom, A.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2019, 29 : S65 - S66
12345